Flossbach Von Storch AG Has $467.44 Million Position in Monsanto Company (MON)
Flossbach Von Storch AG lowered its stake in Monsanto Company (NYSE:MON) by 11.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,901,160 shares of the basic materials company’s stock after selling 495,840 shares during the quarter. Monsanto accounts for 4.9% of Flossbach Von Storch AG’s portfolio, making the stock its 6th largest position. Flossbach Von Storch AG owned about 0.89% of Monsanto worth $467,437,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently modified their holdings of MON. MUFG Securities EMEA plc boosted its stake in shares of Monsanto by 61.9% during the 3rd quarter. MUFG Securities EMEA plc now owns 183,000 shares of the basic materials company’s stock worth $21,927,000 after acquiring an additional 70,000 shares during the last quarter. Norinchukin Bank The boosted its stake in shares of Monsanto by 1.8% during the 3rd quarter. Norinchukin Bank The now owns 114,348 shares of the basic materials company’s stock worth $13,701,000 after acquiring an additional 1,971 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Monsanto by 1.5% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 107,064 shares of the basic materials company’s stock worth $12,828,000 after acquiring an additional 1,626 shares during the last quarter. Assetmark Inc. boosted its stake in shares of Monsanto by 5,841.7% during the 3rd quarter. Assetmark Inc. now owns 34,937 shares of the basic materials company’s stock worth $4,186,000 after acquiring an additional 34,349 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. purchased a new position in shares of Monsanto during the 3rd quarter worth $264,000. Institutional investors own 74.98% of the company’s stock.
In other Monsanto news, CFO Pierre Courduroux sold 4,320 shares of Monsanto stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $122.00, for a total value of $527,040.00. Following the sale, the chief financial officer now directly owns 48,388 shares in the company, valued at approximately $5,903,336. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Brett D. Begemann sold 22,640 shares of Monsanto stock in a transaction on Monday, September 25th. The shares were sold at an average price of $120.03, for a total transaction of $2,717,479.20. Following the completion of the sale, the chief operating officer now owns 85,439 shares in the company, valued at $10,255,243.17. The disclosure for this sale can be found here. Over the last quarter, insiders sold 49,236 shares of company stock worth $5,931,934. 0.79% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY WARNING: “Flossbach Von Storch AG Has $467.44 Million Position in Monsanto Company (MON)” was published by Daily Political and is the sole property of of Daily Political. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright and trademark law. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/11/24/flossbach-von-storch-ag-has-467-44-million-position-in-monsanto-company-mon.html.
Shares of Monsanto Company (NYSE:MON) traded down $0.26 during mid-day trading on Friday, hitting $118.22. 1,847,100 shares of the stock traded hands, compared to its average volume of 1,941,602. The company has a market cap of $52,040.45, a P/E ratio of 21.38, a price-to-earnings-growth ratio of 1.70 and a beta of 1.05. Monsanto Company has a 12-month low of $100.87 and a 12-month high of $122.79. The company has a quick ratio of 0.83, a current ratio of 1.35 and a debt-to-equity ratio of 1.12.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. The firm had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.51 billion. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The company’s revenue was up 4.8% on a year-over-year basis. During the same period last year, the firm earned $0.07 EPS. equities analysts expect that Monsanto Company will post 5.74 earnings per share for the current year.
MON has been the topic of several analyst reports. Zacks Investment Research upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $131.00 price target on the stock in a research note on Tuesday, August 29th. Piper Jaffray Companies set a $128.00 price target on shares of Monsanto and gave the stock a “buy” rating in a research note on Friday, August 11th. BMO Capital Markets reiterated a “buy” rating and set a $128.00 price target on shares of Monsanto in a research note on Friday, September 1st. Barclays PLC reiterated an “equal weight” rating and set a $124.00 price target (up previously from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. Finally, Jefferies Group LLC reiterated a “hold” rating and set a $128.00 price target on shares of Monsanto in a research note on Friday, September 15th. Eleven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Monsanto presently has an average rating of “Hold” and an average target price of $124.61.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.